Načítá se...
Combating COVID-19 with mesenchymal stem cell therapy
The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The virus mainly targets the pulmonary epithelial cells as it’s initial site of infection by letting its surface spike protein interact and bind to the host ACE2 receptor. The internalization and gradual replication o...
Uloženo v:
| Vydáno v: | Biotechnol Rep (Amst) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7224671/ https://ncbi.nlm.nih.gov/pubmed/32420049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.btre.2020.e00467 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|